drugset / Trial / NCT06890416
A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults
RandomizedParallel-groupOpen-labelPrevention
Summary
This purpose of this phase 3 multicenter, parallel-group, open-label study is to learn about the safety, tolerability, and immunogenicity of RSVpreF and HZ/su vaccine when given together in adults 50 years of age and older.
Timeline
- Start
- 2025-04-04
- Primary completion
- 2025-09-30
- Completion
- 2025-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HZ/su | Vaccine | — | Intramuscular |
| Subject | RSVpreF | Vaccine | — | Intramuscular |